Investment Firm Miura Global's Portfolio for Q3 2022 vs. Q4 2022 Shows Major Changes
Ava Hoppe | 10 May, 2023
Investment firm Miura Global Management's 13F filings for Q3 2022 and Q4 2022 show significant changes in their portfolio holdings. The firm's portfolio includes stakes in technology, healthcare, and energy companies, among others. In the Q4 2022 filings, Miura Global added positions in several companies while selling shares in others.
One of the most significant changes in Miura Global's portfolio was their investment in the Israel-based medical technology company InMode Ltd. The firm reduced its stake in InMode Ltd by over 25%, selling approximately 400,000 shares. Similarly, the investment firm reduced its holdings in Capri Holdings Limited, the parent company of luxury fashion brands like Versace and Jimmy Choo, in Q4 2022, but increased its holdings in Netflix, Microsoft, and Visa Inc.
Miura Global made several new investments in Q4 2022, including Boston Scientific Corp and cloud-based cybersecurity company CrowdStrike Holdings Inc. The firm also increased its stakes in energy companies like Cheniere Energy Inc and Antero Resources Corp. However, Miura Global completely sold off its holdings in EQT Corp, Danaher Corporation, and First Citizens Bancshares Inc, as per its Q4 2022 filings.
Among other notable holdings, Miura Global increased its stakes in Ferrari NV, Cloudflare Inc, and Inspire Medical Systems Inc, indicating the firm's confidence in the growth potential of these companies in the coming years. On the other hand, Miura Global reduced its stakes in companies like Dexcom Inc and repligen Corp, considering that these holdings have lower risk returns potential.
Overall, Miura Global Management's portfolio for Q3 2022 vs Q4 2022, as per their 13F filings, highlights their optimistic outlook in technology, energy, and healthcare domains. By adding new positions and selling-off others, the investment firm appears to be continuously assessing and adjusting its portfolio to hold sustainable growth.
Other Posts
- Shapiro Capital Management LLC Q4 2022 vs. Q1 2023: A Look at the Latest Holdings Changes
- Weik Capital Management Q3 2022 vs. Q4 2022: A Look at the Fund’s Holdings Changes
- Progressive Investment's Q4 2022 vs. Q1 2023 Fund Holdings: Winners and Losers
- NWN Carousel: Revolutionizing Cloud Communications and Hybrid Work Solutions in Partnership with American Securities
- Comparing Independence Wealth Advisors' Q3 and Q4 2020: Changes in 13F Holdings
- Antin Infrastructure Partners: Leading the Way in Infrastructure Investments
- EverService: Empowering Growth and Expansion in Tech-Enabled Business Solutions
- Investment Strategies: Analysing Wechter Feldman Wealth Management's Q1 2021 vs Q2 2021 13F Holdings
- Cooke & Bieler LP Q3 to Q4 2022 13F Holdings: Winners and Losers in the Portfolio
- **Enhancing Financial Leadership: Navidea Biopharmaceuticals Hires Craig A. Dais as CFO**